HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moghissi, K. Articles by Pender, D. Search for Related Content PubMed PubMed Citation Articles by Moghissi, K. Articles by Pender, D.

European Journal of Cardio-Thoracic Surgery, Vol 7, 126-131, Copyright © 1993 by European Association for Cardio-thoracic Surgery

ARTICLES

Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study

K Moghissi, DA Sharpe and D Pender
Humberside Cardio-thoracic Surgical Centre, Castle Hill Hospital, Cottingham, North Humberside, UK.

A clinico-pathological study was carried out in two series of patients in order to determine: the prevalence of adenocarcinoma in Barrett's oesophagus in patients undergoing surgical resection for columnar cancer of the oesophagus, the incidence of Barrett's oesophagus in patients with complications of gastro-oesophageal reflux, and the subsequent cancer development in 3-20 years follow-up of such patients, compared with others who had no Barrett's oesophagus. Group 1 consisted of 264 patients with adenocarcinoma of the oesophagus undergoing resection and reconstruction; 18 (6.8%) had concomitant carcinoma and Barrett's oesophagus. These were predominantly male (male/female ratio 8/1) and had worse long-term survival than the other adenocarcinomas. Group 2 consisted of 782 patients with complications of gastro- oesophageal reflux, 26 (3.3%) of whom were found to have Barrett's oesophagus. When followed up for a period of up to 20 years, 4 (15.4%) of these developed cancer in the mean period of 11.5 years (1 case per 74 person-years). This is highly significant compared with 4 others (0.5%) who developed cancer amongst the 756 remaining patients in group 2 with no Barrett's oesophagus, in the mean interval of 8 years 2 months (1 case per over 1500 person-years). Of the 18 patients with Barrett's stricture, 4 (22%) developed cancer at a mean interval of 11.5 years representing one case per 51.7 person-years indicating a higher risk of cancer development in patients with Barrett's stricture compared with other patients with complications of gastro-oesophageal reflux with/without columnar epithelial-lined oesophagus and no stricture. Anti-reflux operation has not protected our patients with Barrett's oesophagus against cancer development.

This article has been cited by other articles:

				M Solaymani-Dodaran, R F A Logan, J West, T Card, and C Coupland Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut, August 1, 2004; 53(8): 1070 - 1074. [Abstract] [Full Text] [PDF]

				N. Shaheen and D. F. Ransohoff Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review JAMA, April 17, 2002; 287(15): 1972 - 1981. [Abstract] [Full Text] [PDF]

				J. Eksteen, A Latchford, S. Thomas, and J. Jankowski Commentary: Regional variations in oesophageal and gastric cardia cancers--implications and practice Int. J. Epidemiol., December 1, 2001; 30(6): 1425 - 1427. [Full Text] [PDF]

				C E Macdonald, A C Wicks, and R J Playford Ten years' experience of screening patients with Barrett's oesophagus in a university teaching hospital Gut, September 1, 1997; 41(3): 303 - 307. [Abstract] [Full Text] [PDF]